Panomifene

Drug Profile

Panomifene

Alternative Names: EGIS 5650; GYKl 13504

Latest Information Update: 14 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IVAX Drug Research Institute
  • Developer Egis Pharmaceuticals; IVAX Drug Research Institute
  • Class Small molecules; Stilbenes
  • Mechanism of Action Estrogen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 26 Oct 1999 IVAX Corporation has acquired the Institute for Drug Research
  • 26 Sep 1997 A clinical study has been added to the pharmacokinetics and adverse events sections
  • 27 May 1997 Phase-II clinical trials for Breast cancer in Hungary (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top